Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

55.6%

5 terminated/withdrawn out of 9 trials

Success Rate

44.4%

-42.1% vs industry average

Late-Stage Pipeline

33%

3 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

5 withdrawn

Enrollment Performance

Analytics

Phase 3
3(100.0%)
3Total
Phase 3(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials
NCT00169975Completed

Efficacy of the CMI Magnetocardiograph in Diagnosing Acute Coronary Syndromes in Patients Presenting With High Risk Unstable Angina.

Role: collaborator

NCT00170027Phase 3Completed

Safety and Efficacy of MCG for Diagnosing Coronary Heart Disease

Role: collaborator

NCT00170014Phase 3Completed

Precision of the Magnetocardiographer for Data Aquision and Analysis.

Role: collaborator

NCT00169936Phase 3Completed

Magnetocardiography as a Non-Invasive Tool for Detecting Tissue Rejection in Heart Transplant Patients

Role: collaborator

NCT00574561Withdrawn

Magnetocardiography (MCG) in Subjects Undergoing CT Angiography (CTA)

Role: collaborator

NCT00574821Withdrawn

Use of Magnetic Field Mapping in the Evaluation of Patients With Hypertrophic Heart Disease (Thick Heart Muscle)

Role: collaborator

NCT00572442Withdrawn

Magnetocardiography (MCG) in Asymptomatic Individuals - Pilot Trial

Role: collaborator

NCT00572286Withdrawn

Non-invasive Evaluation of Heart Transplant Rejection- Pilot Study

Role: collaborator

NCT00572949Withdrawn

Magnetocardiography (MCG) in the Diagnosis of Chest Pain Syndrome

Role: collaborator

All 9 trials loaded